P343: MUTATIONS IN GENES RELATED TO EPIGENETIC REGULATION, TREATMENT RESISTANCE AND IKZF1 PLUS PROFILE IDENTIFY RELAPSE PROFILES IN B-ALL.

• Josgrey del Valle Navas Acosta,
• Teresa Gonzalez,
• Inmaculada Serramito,
• Cristina Miguel,
• Sandra Santos,
• Angela Villaverde,
• Jordi Ribera,
• Isabel Granada,
• Mireia Morgades,
• Ricardo Sánchez,
• Esperanza Such,
• Susana Barrera,
• Juana Ciudad,
• Alberto Orfao,
• Josep Maria Ribera,
• Julio Dávila Valls,
• Natalia De Las Heras Rodriguez,
• José Luis Fuster,
• Alfonso García de Coca,
• Jorge Labrador,
• Jose Antonio Queizan,
• Mª Carmen Mendoza,
• Susana Riesco,
• Rocío Benito,
• Jesus Hernández Rivas

Affiliations

Josgrey del Valle Navas Acosta

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Teresa Gonzalez

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Inmaculada Serramito

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Cristina Miguel

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Sandra Santos

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Angela Villaverde

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Jordi Ribera

3 Hospital Germans Trias i Pujol, Badalona, Spain

Isabel Granada

3 Hospital Germans Trias i Pujol, Badalona, Spain

Mireia Morgades

3 Hospital Germans Trias i Pujol, Badalona, Spain

Ricardo Sánchez

5 Hospital Doce de Octubre, Madrid

Esperanza Such

6 Hospital Universitari i Politecnic La Fe, València, Spain

Susana Barrera

7 Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Juana Ciudad

7 Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Alberto Orfao

7 Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Josep Maria Ribera

3 Hospital Germans Trias i Pujol, Badalona, Spain

Julio Dávila Valls

9 Hospital Nuestra Señora de Sonsoles, Ávila, Spain

Natalia De Las Heras Rodriguez

10 Department of Hematology-Hospital Universitario de León, León, Spain

José Luis Fuster

11 Pediatric Oncohematology Section, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain

Alfonso García de Coca

13 Department of Hematology- Hospital Clínico de Valladolid, Valladolid, Spain

Jorge Labrador

14 Department of Hematology - Hospital Universitario de Burgos, Burgos, Spain

Jose Antonio Queizan

15 Hematology Service - Hospital General de Segovia., Segovia, Spain

Mª Carmen Mendoza

16 Pediatric Service- Hospital Universitario de Salamanca, Salamanca, Spain

Susana Riesco

16 Pediatric Service- Hospital Universitario de Salamanca, Salamanca, Spain

Rocío Benito

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain

Jesus Hernández Rivas

1 University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center., Salamanca, Spain